XML 17 R2.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2024
Mar. 31, 2023
Current assets:    
Cash and cash equivalents $ 253,021 $ 103,093
Accounts receivable-trade, net 644,616 504,122
Accounts receivable-other, net 46,884 55,508
Inventories 139,690 243,286
Financing receivables-net, current 102,600 89,829
Deferred costs 59,449 44,191
Other current assets 27,269 55,101
Total current assets 1,273,529 1,095,130
Financing receivables and operating leases-net 79,435 84,417
Deferred tax asset 5,620 3,682
Property, equipment, and other assets-net 89,289 70,447
Goodwill 161,503 136,105
Other intangible assets-net 44,093 25,045
TOTAL ASSETS 1,653,469 1,414,826
Current liabilities:    
Accounts payable 315,676 220,159
Accounts payable-floor plan 105,104 134,615
Salaries and commissions payable 43,696 37,336
Deferred revenue 134,596 114,028
Other current liabilities 34,630 24,372
Total current liabilities 656,990 561,326
Deferred tax liability 0 715
Other liabilities 81,799 60,998
TOTAL LIABILITIES 751,690 632,561
COMMITMENTS AND CONTINGENCIES (Note 10)
STOCKHOLDERS' EQUITY    
Preferred stock, $0.01 per share par value; 2,000 shares authorized; none outstanding 0 0
Common stock, $0.01 per share par value; 50,000 shares authorized; 26,952 outstanding at March 31, 2024 and 26,905 outstanding at March 31, 2023 274 272
Additional paid-in capital 180,058 167,303
Treasury stock, at cost, 447 shares at March 31, 2024 and 261 shares at March 31, 2023 (23,811) (14,080)
Retained earnings 742,978 627,202
Accumulated other comprehensive income-foreign currency translation adjustment 2,280 1,568
Total Stockholders' Equity 901,779 782,265
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY 1,653,469 1,414,826
Recourse [Member]    
Current liabilities:    
Notes payable-current 0 5,997
Non-recourse [Member]    
Current liabilities:    
Notes payable-current 23,288 24,819
Notes payable - long-term $ 12,901 $ 9,522